Michelle Kittleson
Overview
Explore the profile of Michelle Kittleson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Katz-Greenberg G, Afshar Y, Bonn J, Casale J, Constantinescu S, Defilippis E, et al.
Transplantation
. 2025 Mar;
PMID: 40074722
Solid organ transplantation (SOT) offers people with end-stage organ disease an increased quality of life, which includes the return of fertility and the potential for pregnancy. Although the number of...
2.
Siddiqi T, Packer M, Ezekowitz J, Fonarow G, Greene S, Kittleson M, et al.
JACC Heart Fail
. 2025 Jan;
13(1):14-27.
PMID: 39779178
Several trials have evaluated diuretic-based strategies to improve symptoms and outcomes in patients with acute heart failure (AHF). The authors sought to summarize the effect of different combination strategies on...
3.
Di Mauro M, Kittleson M, Cacioli G, Piazza V, Putini R, Gravino R, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685561
: Pulmonary arterial elastance (Ea) is a helpful parameter to predict the risk of acute postoperative right ventricular failure (RVF) after left ventricular assist device (LVAD) implantation. A new method...
4.
Lee D, Abidi M, Fisher C, Hughart A, Toda M, Williams S, et al.
Transpl Infect Dis
. 2024 Nov;
27(1):e14406.
PMID: 39603983
Background: Coccidioidomycosis is a fungal infection that poses a serious risk when transmitted through organ transplantation. We analyzed cases reported to the Organ Procurement and Transplantation Network ad hoc Disease...
5.
Manla Y, Chang D, Patel J, Kanungo A, Nikolova A, Kransdorf E, et al.
J Heart Lung Transplant
. 2024 Nov;
PMID: 39561862
Background: Primary graft dysfunction (PGD) remains the leading cause of 30-day mortality post-heart transplantation (HTx). HTx recipients experiencing severe PGD have been found to have high levels of circulating proteins...
6.
Baker W, Moore T, Baron E, Kittleson M, Parker W, Jaiswal A
J Heart Lung Transplant
. 2024 Nov;
44(3):462-468.
PMID: 39521197
Background: Missing data decreasing study power and introducing bias, thereby undermining a registry's ability to draw valid inferences. We evaluated how missing data are reported and addressed in heart transplantation...
7.
Kittleson M
J Heart Lung Transplant
. 2024 Nov;
43(11):1818-1819.
PMID: 39490009
No abstract available.
8.
Tang A, Solomon N, Chiswell K, Greene S, Yancy C, Jessup M, et al.
Circ Heart Fail
. 2024 Oct;
17(10):e011795.
PMID: 39381871
Background: Home-time is an emerging, patient-centered outcome that represents the amount of time a patient spends alive and outside of health care facility settings, comprising of hospitals, skilled nursing facilities,...
9.
Peled Y, Ducharme A, Kittleson M, Bansal N, Stehlik J, Amdani S, et al.
J Heart Lung Transplant
. 2024 Aug;
43(10):1529-1628.e54.
PMID: 39115488
The "International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024" updates and replaces the "Listing Criteria for Heart Transplantation: International Society for...
10.
Te H, Lee D, Woolley A, Abidi M, Fisher C, Sellers M, et al.
Transpl Infect Dis
. 2024 Jun;
26 Suppl 1:e14305.
PMID: 38881210
Background: Better access to direct-acting antiviral (DAA) therapy has broadened the utilization of hepatitis C virus (HCV) nucleic acid testing (NAT) positive organs with excellent outcomes. However, DAA therapy has...